T 0926/00 (Treatment of autoimmune diseases/SCHERING) of 26.2.2004

European Case Law Identifier:

ECLI:EP:BA:2004:T092600.20040226

Date of decision:

26 February 2004

Case number:

T 0926/00

Application number:

93923964.6

IPC class:

A61K 31/70

Language of proceedings:

Distribution:

Download and more information:

Decision text in EN (PDF, 62Â KB)
Documentation of the appeal procedure can be found in the Register
Bibliographic information is available in:	EN
Versions:	Unpublished

Title of application:

Fludarabine-5' monophosphate for the treatment of autoimmune diseases

Applicant name:

Schering Aktiengesellschaft

Opponent name:

Board:

3.3.02

Headnote:

Relevant legal provisions:

European Patent Convention 1973 Art 52(1)
European Patent Convention 1973 Art 54
European Patent Convention 1973 Art 56
European Patent Convention 1973 Art 123(2)

Keywords:

Main request: novelty (yes) - use of fludarabine-5' monophosphate for the treatment of autoimmune diseases not directly and unambigously derivable from the cited state of the art; inventive step (no) - skilled person was provided with several hints and suggestions from the prior art pointing him in the direction of the claimed use: obvious to try
Second, third and fourth auxiliary requests - idem
First auxiliary request - contravention of Article 123(2) EPC

Catchwords:

Cited decisions:

T 0296/87
T 0666/89
T 0465/92
T 0511/92

Citing decisions:

Source: http://www.epo.org/law-practice/case-law-appeals/recent/t000926eu1.html

Date retrieved: 17 May 2021